Second Anniversary of Optiscan and Mayo Clinic Agreement
Filed with ASX · · 5 pages · English
Summary by 6ix AI
Optiscan Imaging Limited has announced the second anniversary of its Know-How Agreement with Mayo Clinic, focusing on developing a digital endomicroscopic imaging system for robotic surgery. The collaboration has achieved all key engineering milestones and has been extended to allow for further strategic planning and development activities. Both parties have assessed the integration of this technology into robotic-assisted surgical workflows, aiming to enhance surgical precision. The partnership is significant for Optiscan as it strengthens its position in the robotic surgery market and supports its expansion strategy in the United States.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Optiscan Imaging Limited on 6ix
Story so far
Earlier from Optiscan Imaging
- Optiscan Receives $1.69m R&D Tax Refund
- Optiscan Submits InSpecta FDA Dossier
- Appendix 4D
- Quarterly Activities/Appendix 4C Cash Flow Report
- Optiscan Initiates Head & Neck Cancer Imaging Study
Later from Optiscan Imaging
- Halfway Mark Reached in Optiscan Breast Cancer Study
- Optiscan Launches InSpecta Device for Veterinary Medicine
- Head and Neck Study Progressing Ahead of Schedule
- Optiscan Signs New Research Agreement for Breast Study
- 2026 Annual Report
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging